Skip to main content

Table 2 Baseline clinicopathological characteristics of patients in early recurrence group and non-early recurrence group

From: Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy

Factors Non-early recurrence group Early recurrence group X2 P value
n = 80 n = 81
Sex
 Male 68 73 0.971 0.324
 Female 12 8
Age (years)
 ≤ 55 39 42 0.155 0.694
 > 55 41 39
AST (U/L)
 ≤ 40 60 58 0.237 0.626
 > 40 20 23
ALT (U/L)
 ≤ 40 49 51 0.050 0.823
 > 40 31 30
Total bilirubin (umol/L)
 < 17.1 60 60 0.018 0.893
 ≥ 17.1 20 21
Albumin (g/L)
 < 35 7 15 3.256 0.071
 ≥ 35 73 66
Tumour size (cm)
 ≤ 5 63 40 15.061 < 0.001
 > 5 17 41
Tumour number
 Solitary 73 61 7.328 0.007
 Multiple 7 20
HBV infection
 No 6 6 0.001 0.982
 Yes 74 75
Liver cirrhosis
 No 21 20 0.052 0.820
 Yes 59 61
Vascular invasion
 No 75 57 14.897 < 0.001
 Yes 5 24
Differentiation
 Moderate and well 61 37 15.793 < 0.001
 Poor 19 44
Blood transfusion
 No 48 46 0.171 0.680
 Yes 32 35
Hepatic hilar occlusion
 No 41 40 0.056 0.813
 Yes 39 41
SII
 ≤ 330 57 51 1.252 0.263
 > 330 23 30
MLR
 ≤ 0.25 49 16 28.790 < 0.001
 > 0.25 31 65
NLR
 ≤ 2.74 71 55 10.283 0.001
 > 2.74 9 26
PLR
 ≤ 88 54 41 4.743 0.029
 > 88 26 40
SIRI
 ≤ 1.03 60 42 9.289 0.002
 > 1.03 20 39
AFP (ng/mL)
 < 400 65 53 5.145 0.023
 ≥ 400 15 28
ALBI grade
 1 47 40 1.422 0.233
 2 33 41
BCLC stage
 0–A 68 47 14.351 < 0.001
 B–C 12 34
  1. AST aspartate aminotransferase, ALT alanine aminotransferase, HBV hepatitis B virus, AFP alpha fetoprotein, ALBI albumin–bilirubin, BCLC Barcelona Clinic Liver Cancer
\